Point: Myeloperoxidase -463G → A polymorphism and lung cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 12, 2002, Pages 1550-1554

  Feyler, Anne ^a   Voho, Anu ^b   Bouchardy, Christine ^c   Kuokkanen, Katja ^b   Dayer, Pierre ^d   Hirvonen, Ari ^b   Benhamou, Simone ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c GENEVA CANCER REGISTRY   (Switzerland)

^d UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; CARCINOGEN; CYTOCHROME P450 1A1; DNA; GLUTATHIONE TRANSFERASE; MYELOPEROXIDASE; TOBACCO SMOKE; PEROXIDASE;

ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHEMICAL CARCINOGENESIS; CIGARETTE SMOKING; CONTROLLED STUDY; GENE MUTATION; GENOTYPE; HUMAN; LUNG CANCER; LUNG DISEASE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; LUNG TUMOR; MALE; META ANALYSIS; METHODOLOGY; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY; PROBABILITY; PROGNOSIS; RISK; RISK ASSESSMENT; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

AGED; BASE SEQUENCE; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; ODDS RATIO; PEROXIDASE; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE;

EID: 0036885798     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Foster, C. B., Lehrnbecher, T., Mol, F., Steinberg, S. M., Venzon, D. J., Walsh, T. J., Noack, D., Rae, J., Winkelstein, J. A., Curnutte, J. T., and Chanock, S. J. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J. Clin. Investig., 102: 2146-2155, 1998.
2. Hunninghake, G. W., and Crystal, R. G. Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am. Rev. Respir. Dis., 128: 833-838, 1983.
3. Schmekel, B., Karlsson, S. E., Linden, M., Sundstrom, C., Tegner, H., and Venge, P. Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity. Inflammation, 14: 447-454, 1990.
4. Mallet, W. G., Mosebrook, D. R., and Trush, M. A. Activation of (+-)-trans-7, 8-dihydroxy-7, 8-dihydrobenzo[a]pyrene to diolepoxides by human polymorphonuclear leukocytes or myeloperoxidase. Carcinogenesis (Lond.), 12: 521-524, 1991.
5. Petruska, J. M., Mosebrook, D. R., Jakab, G. J., and Trush, M. A. Myeloperoxidase-enhanced formation of (+-)-trans-7, 8-dihydroxy-7, 8-dihydrobenzo-[a]pyrene-DNA adducts in lung tissue in vitro: A role of pulmonary inflammation in the bioactivation of a procarcinogen. Carcinogenesis (Lond.), 13: 1075-1081, 1992.
6. Piedrafita, F. J., Molander, R. B., Vansant, G., Orlova, E. A., Pfahl, M., and Reynolds, W. F. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J. Biol. Chem., 271: 14412-14420, 1996.
7. London, S. J., Lehman, T. A., and Taylor, J. A. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res., 57: 5001-5003, 1997.
8. Cascorbi, I., Henning, S., Brockmöller, J., Gephart, J., Meisel, C., Müller, J. M., Loddenkemper, R., and Roots, I. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant -463A of the myeloperoxidase gene. Cancer Res., 60: 644-649, 2000.
9. Le Marchand, L., Seifried, A., Lum, A., and Wilkens, L. R. Association of the myeloperoxidase -463G-A polymorphism with lung cancer risk. Cancer Epidemiol. Biomark. Prev., 9: 181-184, 2000.
10. Schabath, M. B., Spitz, M. R., Zhang, X., Delclos, G. L., and Wu, X. Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis (Lond.), 21: 1163-1166, 2000.
11. Misra, R. R., Tangrea, J. A., Virtamo, J., Ratnasinghe, D., Andersen, M. R., Berrett, M., Taylor, P. R., and Albanes, D. Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland. Cancer Lett., 164: 161-167, 2001.
12. Bouchardy, C., Wikman, H., Benhamou, S., Hirvonen, A., Dayer, P., and Husgafvel-Pursiainen, K. CYP1A1 genetic polymorphisms, tobacco smoking and lung cancer risk in a French Caucasian population. Biomarkers, 2: 131-134, 1997.
13. Jourenkova-Mironova, N., Wikman, H., Bouchardy, C., Voho, A., Dayer, P., Benhamou, S., and Hirvonen, A. Role of glutathion S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. Pharmacogenetics, 8: 495-502, 1998.
14. IARC. Tobacco Smoking. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. IARC Sci. Publ., 38: 55, 1986.
15. Breslow, N. E., and Day, N. E. Statistical Methods in Cancer Research. I. The Analysis of Case-Control Studies. IARC Scientific Publ. No. 32, pp. 192-242. Lyon, France: IARC, 1980.
16. Schabath, M. B., Spitz, M. R., Hong, W. K., Delclos, G. L., Reynolds, W. F., Gunn, G. B., Withehead, L. W., and Wu, X. A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung Cancer, 37: 35-40, 2002.
17. DerSimonian, R., and Laird, N. M. Meta-analysis in clinical trials. Control. Clin. Trials 7: 177-188, 1986.
18. Greenland, S. Meta-analysis. In: K. J. Rothman and S. Greenalnd (eds.), Modern Epidemiology. Philadelphia: Lippincott-Raven, 1998.
19. Egger, M., Smith, G. D., Schneider, M., and Minder, C. Bias in meta-analysis detected by a simple graphical test. Br. Med. J., 315: 629-634, 1997.